|
|
|
|
NAME
T-20, Pentafuside |
BRAND
Not yet established |
CLASS
Experimental fusion inhibitor |
COST
Not yet established because of experimental drug status |
STANDARD DOSE
Taken as self-administered, twice daily subcutaneous injections. Dose not yet established because of experimental drug status |
POTENTIAL SIDE EFFECTS
Irritation or infection at site of injection, fever, headache. |
POTENTIAL DRUG INTERACTIONS
Not yet reported. |
|
|
|
|
|
|
 |
|
